| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/22/1993 | CA2127365A1 Amino acid derivatives as paf-receptor antagonists |
| 07/22/1993 | CA2127251A1 Heterocyclic compounds and their preparation and use |
| 07/22/1993 | CA2126687A1 Substituted phosphinic acid-containing peptidyl derivatives as antidegenerative agents |
| 07/22/1993 | CA2125182A1 Piperazine derivatives as 5-ht receptors antagonists |
| 07/22/1993 | CA2124217A1 Inactivation of cytotoxic drugs |
| 07/22/1993 | CA2105284A1 Dna encoding a human 5-ht 1f receptor and uses thereof |
| 07/22/1993 | CA2087510A1 Method of using m1-selective antimuscarinic pyridobenzodiazepiones in axial myopia therapy |
| 07/21/1993 | EP0552106A1 Peptide antagonists of bradykinin |
| 07/21/1993 | EP0551963A2 Use of heterocyclic derivatives for the manufacture of medicaments |
| 07/21/1993 | EP0551927A1 Method for the treatment of cardiac insufficiency |
| 07/21/1993 | EP0551662A1 Benzofuranyl- and thiophenylmethylthio-alcanecarboxylic acid derivatives |
| 07/21/1993 | EP0551432A1 4,5,6,7-tetrahydro-1h-imidazo 4,5-c]pyridine derivatives and analogues as angiotensin ii receptor antagonists |
| 07/21/1993 | CN1074370A Composition for accelerating wound healing |
| 07/20/1993 | US5229505 CNS and cardiovascular effects |
| 07/20/1993 | US5229417 2-(3-phenylpropyl)hydrazines and method of treating personality disorders |
| 07/20/1993 | US5229412 Administering carrier with anxiolytic derivatives of N-(3-/4-indolyloxy/-2-hydroxypropyl)-1,8-diamino-p-menthane |
| 07/20/1993 | US5229410 Antidepressant, tranquilizers |
| 07/20/1993 | US5229409 6-substituted-tetrahydrobenz[cd]indoles |
| 07/20/1993 | US5229399 Analgesics |
| 07/20/1993 | US5229392 2-aminopyrimidine-4-carboxamide derivatives, their preparaton and their application in therapy |
| 07/20/1993 | CA1320498C2 Methods and compositions for inhibiting lipoxygenase |
| 07/20/1993 | CA1320492C Process for the preparation of novel 2-thienyl-oxyacetic acid derivatives |
| 07/20/1993 | CA1320490C Anti-inflammatory agents |
| 07/20/1993 | CA1320449C Methods and compositions for thrombolytic therapy |
| 07/18/1993 | CA2087379A1 Pseudopeptidic derivatives having an antigonistic activity for bradykinine, process for their preparation and pharmaceutical compositions containing them |
| 07/16/1993 | WO1993014096A1 Phosphono derivatives of amino acids as metalloproteinase inhibitors |
| 07/16/1993 | CA2105309A1 Phosphono derivatives of amino acids as metalloproteinase inhibitors |
| 07/14/1993 | EP0551182A1 Method of treating hyperproliferative vascular disease using rapamycin, eventually in combination with mycophenolic acid |
| 07/14/1993 | EP0551077A2 Pharmaceutical composition comprising atrial nutriuretic peptide for treatment of adult respiratory distress syndrome |
| 07/14/1993 | EP0550895A1 4,13-dioxabicyclo (8.2.1) tridecenon-derivatives, method and intermediates for their preparation, and medicaments containing the same |
| 07/14/1993 | EP0550668A1 Ibuprofen-antihistamine combinations |
| 07/14/1993 | EP0550568A1 Anti-atherosclerotic aryl compounds |
| 07/14/1993 | EP0550566A1 Antiproliferative substituted naphthalene compounds |
| 07/14/1993 | EP0550550A1 3,9-diazabicyclo (3.3.1) nonan-7-yl derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them |
| 07/14/1993 | EP0550507A1 Indole ureas as 5 ht receptor antagonist |
| 07/14/1993 | EP0550502A1 Substituted imidazoles, their preparation and pharmaceutical compositions |
| 07/14/1993 | EP0550458A1 Bone growth stimulator. |
| 07/14/1993 | EP0550446A1 Radioprotection by calcium antagonists |
| 07/14/1993 | CA2086987A1 Benzofuranyl- and thiophenylmethylthio-alkanecarboxylic acid derivatives |
| 07/13/1993 | US5227518 L-carnitine derivatives as therapeutical agents for treating myopathies and neuronal degeneration and for inhibiting proteolysis |
| 07/13/1993 | US5227393 α-fluoro-α-tetrazolyl-phenylmethyl derivatives useful as aromatase inhibitors |
| 07/13/1993 | US5227385 Method for treatment of neurodegenerative diseases |
| 07/13/1993 | US5227158 Method of stimulating hepatocyte proliferation by administration of hepatocyte growth factor and gamma-interferon |
| 07/13/1993 | CA1320203C2 Intermediates for 9-deazaguanines |
| 07/13/1993 | CA1320133C Analgesic drug comprising l-tryptophan |
| 07/08/1993 | WO1993013121A1 Gapped 2' modified oligonucleotides |
| 07/08/1993 | WO1993013114A1 COMPOSITIONS AND METHODS FOR MODULATING β-AMYLOID |
| 07/08/1993 | WO1993013089A1 Macrocyclic polyether carboxylic acids |
| 07/08/1993 | WO1993013083A1 Oxadiazole derivatives having acetylcholinesterase-inhibitory and muscarinic agonist activity |
| 07/08/1993 | WO1993013055A1 Amidino derivatives and their use as nitric oxide synthase inhibitors |
| 07/08/1993 | WO1993012808A1 A method for treating kaposi's sarcoma and blocking or inhibiting vascular permeability |
| 07/08/1993 | WO1993012786A1 Indolinone derivatives |
| 07/08/1993 | WO1993012785A1 Use of 5-ht4 modulators for the manufacture of a medicament for the treatment of the bladder diseases |
| 07/08/1993 | WO1993012780A1 Potentiation of nmda antagonists |
| 07/08/1993 | WO1993012779A1 Compositions containing histamine-h2-receptor antagonists at low dosage |
| 07/08/1993 | WO1993012754A2 Tertiary and secondary amines as alpha-2 antagonists and serotonin uptake inhibitors |
| 07/08/1993 | CA2126976A1 Oxadiazole derivatives having acetylcholinesterase-inhibitory and muscarinic agonist activity |
| 07/08/1993 | CA2126451A1 Compositions and methods for modulating .beta.-amyloid |
| 07/08/1993 | CA2126231A1 Compositions containing histamine-h2-receptor antagonists at low dosage |
| 07/08/1993 | CA2126108A1 A method for treating kaposi's sarcoma and blocking or inhibiting vascular permeability |
| 07/08/1993 | CA2125392A1 Tertiary and secondary amines as alpha-2-antagonists and serotonin uptake inhibitors |
| 07/08/1993 | CA2124799A1 Potentiation of nmda antagonists |
| 07/07/1993 | EP0550112A1 2-Saccharinylmethyl aryl and aryloxy acetates useful as proteolytic enzyme inhibitors and pharmaceutical compositions contaning them |
| 07/07/1993 | EP0550111A1 2-Saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and pharmaceutical compositions containing them |
| 07/07/1993 | EP0549879A2 Thiazol substituted quinolylmethoxyphenylacetic acid derivatives |
| 07/07/1993 | EP0549804A1 Acat inhibitor |
| 07/07/1993 | EP0549797A1 Isoxazole compound, pharmaceutically acceptable salt thereof, and medicinal use thereof |
| 07/07/1993 | EP0549711A1 Natural killer stimulatory factor |
| 07/07/1993 | EP0549702A1 Uses of recombinant colony stimulating factor-1 |
| 07/07/1993 | EP0549686A1 Modified internucleoside linkages |
| 07/07/1993 | EP0549660A1 Enhancement of glutathione levels with glutamine |
| 07/07/1993 | EP0549600A1 5-trifluoroacylamino-2-aryl oxazoles |
| 07/07/1993 | EP0538330A4 Beta-alethine use in cell culture and therapy |
| 07/06/1993 | US5225531 Hexapeptide Lys Gly Ala Gly Asp Val |
| 07/06/1993 | US5225433 Selective, photosensitivity |
| 07/06/1993 | US5225426 Thiazolidine-2,4-dione compound and method of treatment of diabetic complications |
| 07/06/1993 | US5225422 Pyridine compounds which are useful as leukotriene b4 antagonist |
| 07/06/1993 | US5225414 Substituted azoles, a process for their preparation, and their use |
| 07/06/1993 | US5225401 Endopeptidase inhibitors for congestive heart failure |
| 07/06/1993 | US5225238 Method for coating active principles with a ph-sensitive polymer |
| 07/01/1993 | CA2086348A1 2-saccharinylmethyl aryl and aryloxy acetates useful as proteolytic enzyme inhibitors and compositions and method of use thereof |
| 07/01/1993 | CA2086346A1 2-saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof |
| 06/30/1993 | EP0549407A1 Novel pyrrolidine derivatives, process for their preparation and pharmaceutical compositions containing them |
| 06/30/1993 | EP0549348A1 Arylidene-heterocyclic derivatives, process for their preparation and their use as tyrisine kinase inhibitors |
| 06/30/1993 | EP0549318A2 26,27-Dimethylene-1 alpha, 25-dihydroxyvitamin D2 and 26,27-dihydroxyvitamin D2 and methods for preparing same |
| 06/30/1993 | EP0549041A1 17-Spirofuran-3'-ylidene steroids |
| 06/30/1993 | EP0549039A1 3-Phenylureido-1,4-Benzodiazepinones and their use as cholecystokinin or gastrin antagonists |
| 06/30/1993 | EP0548949A2 Fused benzeneoxyacetic acid derivatives |
| 06/30/1993 | EP0548884A1 Biphosphonate derivative |
| 06/30/1993 | EP0548825A1 Bradykinin-antagonists for the treatment of acute pancreatitis |
| 06/30/1993 | EP0548327A1 2,14-disubstituted ergolines, their production and use in medicaments |
| 06/30/1993 | EP0548291A1 Pyridylthio or pyridyloxy alkanoic acids |
| 06/30/1993 | EP0548254A1 6- or 7- (2-IMINO-2-IMIDAZOLIDINE)-1,4-BENZOXAZINES AS ALPHA ADRENERGIC AGENTS |
| 06/30/1993 | EP0548238A1 Non-aqueous liquid oral suspensions |
| 06/30/1993 | EP0548235A1 Synthetic drug molecules that mimic metalloenzymes |
| 06/30/1993 | EP0548227A1 Compounds |
| 06/30/1993 | EP0441939A4 Wound healing |
| 06/30/1993 | EP0343223B1 Use of melatonin or derivatives thereof for the production of pharmaceutical compositions effective to counteract the effects of aging |
| 06/30/1993 | CN1073677A 20-methyl-substituted vitamin D-derivatives |
| 06/30/1993 | CN1073603A Anetic kinin antagon for curing acute pancreatitis |